Clinical Trial Update: Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a single dose of erythropoietin for acute myocardial ischemia has completed. The study was sponsored by University Medical Center Gro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: CABG, Coronary Artery Disease | Phase 2 | Status: COMPLETED